低脂高纤维饮食降低溃疡性结肠炎炎症与菌群失调标志物并改善生活质量
本研究为平行组交叉试验,纳入17例缓解期或轻度活动期溃疡性结肠炎患者,随机接受低脂高纤维饮食(脂肪供能10%)或改良标准美式饮食(脂肪供能35%-40%)各4周,中间洗脱2周。结果显示两种饮食均改善生活质量,但低脂高纤维饮食显著降低血清淀粉样蛋白A并减少粪便菌群失调。
要点
- 低脂高纤维饮食可降低UC患者血清炎症标志物及粪便菌群失调。
- 低脂高纤维饮食与改良标准美式饮食均能改善患者生活质量。
- 饮食干预可能使缓解期UC患者获益,但需更大样本验证。
核心结论
- 在缓解期UC患者中,低脂高纤维饮食和改良标准美式饮食均耐受良好并提高生活质量,但低脂高纤维饮食还能降低炎症标志物并减少粪便菌群失调。
研究设计与样本
- 平行组交叉研究,纳入17例缓解期或轻度UC患者(过去18个月内有 flare),随机分为2组,先接受低脂高纤维饮食(脂肪供能10%)或改良标准美式饮食(脂肪供能35%-40%)4周,洗脱2周后交换饮食4周,所有饮食由研究提供并送至患者家中,患者自身对照。
临床怎么用
- 对于缓解期UC患者,可考虑采用低脂高纤维饮食作为辅助干预,以改善生活质量和降低炎症及菌群失调标志物。
- 饮食干预需个体化,并监测患者耐受性和营养状况。
局限性
- 样本量小(17例),研究结果需在更大规模人群中验证。
- 研究期间所有患者维持缓解,对活动期患者的适用性未知。
- 饮食由研究提供并配送,真实世界依从性可能不同。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: A high-fat diet has been associated with an increased risk of ulcerative colitis (UC). We studied the effects of a low-fat, high-fiber diet (LFD) vs an improved standard American diet (iSAD, included higher quantities of fruits, vegetables, and fiber than a typical SAD). We collected data on quality of life, markers of inflammation, and fecal markers of intestinal dysbiosis in patients with UC. METHODS: We analyzed data from a parallel-group, cross-over study of 17 patients with UC in remission or with mild disease (with a flare within the past 18 mo), from February 25, 2015, through September 11, 2018. Participants were assigned randomly to 2 groups and received a LFD (10% of calories from fat) or an iSAD (35%-40% of calories from fat) for the first 4-week period, followed by a 2-week washout period, and then switched to the other diet for 4 weeks. All diets were catered and delivered to patients' homes, and each participant served as her or his own control. Serum and stool samples were collected at baseline and week 4 of each diet and analyzed for markers of inflammation. We performed 16s ribosomal RNA sequencing and untargeted and targeted metabolomic analyses on stool samples. The primary outcome was quality of life, which was measured by the short inflammatory bowel disease (IBD) questionnaire at baseline and week 4 of the diets. Secondary outcomes included changes in the Short-Form 36 health survey, partial Mayo score, markers of inflammation, microbiome and metabolome analysis, and adherence to the diet. RESULTS: Participants' baseline diets were unhealthier than either study diet. All patients remained in remission throughout the study period. Compared with baseline, the iSAD and LFD each increased quality of life, based on the short IBD questionnaire and Short-Form 36 health survey scores (baseline short IBD questionnaire score, 4.98; iSAD, 5.55; LFD, 5.77; baseline vs iSAD, P = .02; baseline vs LFD, P = .001). Serum amyloid A decreased significantly from 7.99 mg/L at baseline to 4.50 mg/L after LFD (P = .02), but did not decrease significantly compared with iSAD (7.20 mg/L; iSAD vs LFD, P = .07). The serum level of C-reactive protein decreased numerically from 3.23 mg/L at baseline to 2.51 mg/L after LFD (P = .07). The relative abundance of Actinobacteria in fecal samples decreased from 13.69% at baseline to 7.82% after LFD (P = .017), whereas the relative abundance of Bacteroidetes increased from 14.6% at baseline to 24.02% on LFD (P = .015). The relative abundance of Faecalibacterium prausnitzii was higher after 4 weeks on the LFD (7.20%) compared with iSAD (5.37%; P = .04). Fecal levels of acetate (an anti-inflammatory metabolite) increased from a relative abundance of 40.37 at baseline to 42.52 on the iSAD and 53.98 on the LFD (baseline vs LFD, P = .05; iSAD vs LFD, P = .09). The fecal level of tryptophan decreased from a relative abundance of 1.33 at baseline to 1.08 on the iSAD (P = .43), but increased to a relative abundance of 2.27 on the LFD (baseline vs LFD, P = .04; iSAD vs LFD, P = .08); fecal levels of lauric acid decreased after LFD (baseline, 203.4; iSAD, 381.4; LFD, 29.91; baseline vs LFD, P = .04; iSAD vs LFD, P = .02). CONCLUSIONS: In a cross-over study of patients with UC in remission, we found that a catered LFD or iSAD were each well tolerated and increased quality of life. However, the LFD decreased markers of inflammation and reduced intestinal dysbiosis in fecal samples. Dietary interventions therefore might benefit patients with UC in remission. ClinicalTrials.gov no: NCT04147598.
引用
- Fritsch J, Garces L, Quintero MA, et al. Low-Fat, High-Fiber Diet Reduces Markers of Inflammation and Dysbiosis and Improves Quality of Life in Patients With Ulcerative Colitis. Clin Gastroenterol Hepatol. 2020. PMID: 32445952. doi:10.1016/j.cgh.2020.05.026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。